8
Apr

COVID-19 update: Genoskin expands R&D capabilities

COVID-19 update: Genoskin R&D capabilities expanded As the COVID-19 outbreak continues to evolve, our priorities remain safety and contingency in supporting research and first responders. Globally, hospitals are now focused on life-saving efforts. All non-urgent surgeries have therefore been postponed to help hospitals deal with the increasingly high demand of ventilators. These new measures have impacted our sourcing network in
Read more
18
Mar

Genoskin maintains US lab activity amid COVID-19 pandemic

COVID-19 update: Genoskin to maintain US production activity during pandemic. In light of the latest updates on the COVID-19 pandemic, Genoskin’s top priority remains both employees and collaborators’ safety. Thanks to the ability to rely on skin expertise and model production in the US location (Salem, MA), Genoskin continues to provide partners with the available support needed in reliably and quickly

Read more

13
Mar

Genoskin supports CoViD19 research!

Genoskin COVID-19 research preferred access program On Friday, March 13th 2020, Genoskin launched a preferred access program for all research teams actively developing therapeutic and vaccine technologies for the COVID-19 pandemic. The World Health Organization (WHO) officially declared on March 11th, the outbreak of COVID-19 a pandemic. The disease caused by SARS-CoV-2 has spread globally. Over 130,000 individuals are affected so

Read more

4
Mar

Top differences between human and animal skin

Top differences between human and animal skin Are animal models used in skin research? Animal models have been widely used in skin research. They are often used to study percutaneous absorption, wound healing, skin inflammation and psoriasis. These studies require relevant models in terms of structure and immunology to assess human skin response and to de-risk clinical trials on humans. The
Read more
28
Feb

6 steps to get your new product approved by FDA

6 steps to get your new product approved by FDA In the USA, any new drug or biologic needs a stamp of approval from the Food and Drug Administration (FDA) before going to the market. The development of a new drug and the approval process can be long and difficult. To make it easier for you, we have gathered below
Read more
26
Feb

Come with us at SOT2020 next month!

Join us at SOT2020! Genoskin team is getting ready for the SOT2020 Annual Meeting and ToxExpo next month in Anaheim, CA. Our skin experts, Yolaine Robitaille, Field Application Director, and Eric Merle, CCO are excited to meet you at booth #1200. Take the opportunity to come by and learn more about how our ex vivo human skin assays predict injection
Read more